Oral Antidiabetic Drugs During Ramadhan
As compared to oral hypoglycemic agents OHAs and sulfonylureas SUs which carry a higher and significant risk of hypoglycemia newer antidiabetic agents such as dipeptidyl peptidase-4 DPP-4 inhibitors have demonstrated lower risk of hypoglycemia during Ramadan fasting with better patient compliance. Fasting and after T3. Insulin During Ramadan Cpg T2dm 5th Ed Ramadan Insulin Iftar The aim of this study was to assess the safety of a protocol involving dose adjustments to four different anti-diabetic. . Majority of diabetics had poorly controlled Fasting Blood Sugar FBS and Body Mass Index BMI. Older long acting sulfonylureas like glibenclamide and chlorpropamide should be avoided during fasting. With the advent of newer anti-diabetic agents there is a good scope for better control and reduced complications. There was little or no change in the lifestyle activities and InsulinOral AntiDiabetic Drug OAD doses during Ramadan. Pa...